These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34035022)

  • 41. Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review.
    Pizzi MA; Alejos D; Hasan TF; Atwal PS; Krishnaiengar SR; Freeman WD
    Neurohospitalist; 2019 Jan; 9(1):30-36. PubMed ID: 30671162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N; Landry KB; Fargason RE; Birur B
    Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing valproic acid toxicity-related hyperammonaemia: an unpredicted course.
    Pagali S; Edquist C; O'Rourke N
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33875509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute onset of ornithine transcarbamylase deficiency after total anomalous pulmonary venous connection repair to a 2-day-old neonate.
    Yoshida H; Iwata Y; Fuchigami T; Katagiri J
    Cardiol Young; 2023 Sep; 33(9):1775-1776. PubMed ID: 37042609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.
    Kim YM; Lee BH; Choi JH; Kim GH; Lim HH; Yoo HW
    Gene; 2013 Sep; 527(1):394-6. PubMed ID: 23769969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unusual case of sodium valproate-induced hyperammonaemia encephalopathy.
    Ranjith S; Abeysundera H; Jeyaranjan H
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 38035682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An OTC deficiency 'phenocopy' in association with Klinefelter syndrome.
    Swarts L; Leisegang F; Owen EP; Henderson HE
    J Inherit Metab Dis; 2007 Feb; 30(1):101. PubMed ID: 17186414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency.
    Gulati S; Menon S; Kabra M; Kalra V
    Indian J Pediatr; 2004 Jul; 71(7):645-7. PubMed ID: 15280615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ornithine transcarbamoylase deficiency presenting with acute liver failure.
    Mustafa A; Clarke JT
    J Inherit Metab Dis; 2006 Aug; 29(4):586. PubMed ID: 16802108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
    Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
    J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vomiting, ataxia, and altered mental status in an adolescent: late-onset ornithine transcarbamylase deficiency.
    Myers JH; Shook JE
    Am J Emerg Med; 1996 Oct; 14(6):553-7. PubMed ID: 8857803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute hyperammonaemic encephalopathy in a female newborn caused by a novel, de novo mutation in the ornithine transcarbamylase gene.
    Valik D; Sedova Z; Starha J; Zeman J; Hruba E; Dvorakova L
    Acta Paediatr; 2004 May; 93(5):710-1. PubMed ID: 15174800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ornithine transcarbamylase deficiency: a urea cycle defect.
    Gordon N
    Eur J Paediatr Neurol; 2003; 7(3):115-21. PubMed ID: 12788037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hiding in Plain Sight: A Case of Ornithine Transcarbamylase Deficiency Unmasked Post-Liver Transplantation.
    Ramanathan M; Uppalapu S; Patel NM
    Am J Transplant; 2017 May; 17(5):1405-1408. PubMed ID: 27997078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
    Choi JH; Lee BH; Kim JH; Kim GH; Kim YM; Cho J; Cheon CK; Ko JM; Lee JH; Yoo HW
    J Hum Genet; 2015 Sep; 60(9):501-7. PubMed ID: 25994866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late-Onset Ornithine Transcarbamylase Deficiency Complicated with Extremely High Serum Ammonia Level: Prompt Induction of Hemodialysis as the Key to Successful Treatment.
    Yamamoto S; Yamashita S; Kakiuchi T; Kurogi K; Nishi TM; Tago M; Yamashita SI
    Am J Case Rep; 2022 Nov; 23():e937658. PubMed ID: 36377209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult-onset ornithine transcarbamylase deficiency as a rare cause of fatal hyperammonaemia.
    Durer S; Durer C; Hoilat GJ
    Lancet; 2021 Aug; 398(10302):e11. PubMed ID: 34454677
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
    Izadi Firouzabadi L; Geer K; Mead P;
    Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004
    [No Abstract]   [Full Text] [Related]  

  • 59. Late-onset ornithine transcarbamylase deficiency: a potentially fatal yet treatable cause of coma.
    Crosbie DC; Sugumar H; Simpson MA; Walker SP; Dewey HM; Reade MC
    Crit Care Resusc; 2009 Sep; 11(3):222-7. PubMed ID: 19737127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.
    Lipskind S; Loanzon S; Simi E; Ouyang DW
    J Perinatol; 2011 Oct; 31(10):682-4. PubMed ID: 21956151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.